Taste alterations after hematopoietic cell transplantation: a scoping review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Taste alterations after hematopoietic cell transplantation: a scoping review ; volume:32 ; number:10 ; day:25 ; month:9 ; year:2024 ; pages:1-11 ; date:10.2024
Supportive care in cancer ; 32, Heft 10 (25.9.2024), 1-11, 10.2024
- Urheber
-
Dequae, Caroline G. R.
Raber-Durlacher, Judith E.
Epstein, Joel B.
Vries, Ralph de
Laheij, Alexa M. G. A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-024-08900-w
- URN
-
urn:nbn:de:101:1-2501082103166.845357636629
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dequae, Caroline G. R.
- Raber-Durlacher, Judith E.
- Epstein, Joel B.
- Vries, Ralph de
- Laheij, Alexa M. G. A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Endothelial Dysfunction in Hematopoietic Cell Transplantation
Hematopoietic cell transplantation in children with cancer
Cardiovascular Complications of Hematopoietic Stem Cell Transplantation
Hematopoietic stem cells : animal models and human transplantation
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Cardiovascular Considerations in Patients Undergoing Hematopoietic Cell Transplantation
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience
Expansion of hematopoietic stem cells for transplantation: current perspectives
The EBMT Handbook : Hematopoietic Cell Transplantation and Cellular Therapies
Hematopoietic stem cell transplantation for hemoglobinopathies: Progress and prospects
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Endothelial Dysfunction in Hematopoietic Cell Transplantation
Hematopoietic cell transplantation in children with cancer
Cardiovascular Complications of Hematopoietic Stem Cell Transplantation
Hematopoietic stem cells : animal models and human transplantation
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Cardiovascular Considerations in Patients Undergoing Hematopoietic Cell Transplantation
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience
Expansion of hematopoietic stem cells for transplantation: current perspectives
The EBMT Handbook : Hematopoietic Cell Transplantation and Cellular Therapies
Hematopoietic stem cell transplantation for hemoglobinopathies: Progress and prospects
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Endothelial Dysfunction in Hematopoietic Cell Transplantation
Hematopoietic cell transplantation in children with cancer
Cardiovascular Complications of Hematopoietic Stem Cell Transplantation
Hematopoietic stem cells : animal models and human transplantation
Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation
Cardiovascular Considerations in Patients Undergoing Hematopoietic Cell Transplantation
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience
Expansion of hematopoietic stem cells for transplantation: current perspectives
The EBMT Handbook : Hematopoietic Cell Transplantation and Cellular Therapies
Hematopoietic stem cell transplantation for hemoglobinopathies: Progress and prospects